DE1274126B - Process for the preparation of 1ª ‡ -alkylthio-3-keto-4-androstenes - Google Patents
Process for the preparation of 1ª ‡ -alkylthio-3-keto-4-androstenesInfo
- Publication number
- DE1274126B DE1274126B DEM55037A DEM0055037A DE1274126B DE 1274126 B DE1274126 B DE 1274126B DE M55037 A DEM55037 A DE M55037A DE M0055037 A DEM0055037 A DE M0055037A DE 1274126 B DE1274126 B DE 1274126B
- Authority
- DE
- Germany
- Prior art keywords
- hydrogen atom
- carbon atoms
- acid
- keto
- alkylthio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 20
- -1 alkyl mercaptan Chemical compound 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 239000011541 reaction mixture Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229910052731 fluorine Chemical group 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 229920006395 saturated elastomer Chemical group 0.000 claims description 2
- 229930195734 saturated hydrocarbon Chemical group 0.000 claims description 2
- 229930195735 unsaturated hydrocarbon Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 238000002955 isolation Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 229960001566 methyltestosterone Drugs 0.000 description 4
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 229960003604 testosterone Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000001195 anabolic effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- RSIHSRDYCUFFLA-DYKIIFRCSA-N boldenone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 RSIHSRDYCUFFLA-DYKIIFRCSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- RSIHSRDYCUFFLA-UHFFFAOYSA-N dehydrotestosterone Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 RSIHSRDYCUFFLA-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- KJRCEJOSASVSRA-UHFFFAOYSA-N propane-2-thiol Chemical compound CC(C)S KJRCEJOSASVSRA-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 1
- SGXDXUYKISDCAZ-UHFFFAOYSA-N N,N-diethylglycine Chemical class CCN(CC)CC(O)=O SGXDXUYKISDCAZ-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000158147 Sator Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KPCDGGNHYODURF-PXQJOHHUSA-N [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 KPCDGGNHYODURF-PXQJOHHUSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 229940070021 anabolic steroids Drugs 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 239000012374 esterification agent Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000015244 frankfurter Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Description
BUNDESREPUBLIK DEUTSCHLAND DEUTSCHES ^VQ^ PATENTAMTFEDERAL REPUBLIC OF GERMANY GERMAN ^ VQ ^ PATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. Cl.:Int. Cl .:
Deutsche Kl.:German class:
Nummer:
- Aktenzeichen:
Anmeldetag:
Auslegetag:Number:
- File number:
Registration date:
Display day:
C07cC07c
A61kA61k
12 ο-25/0412 ο-25/04
30 h-2/1030 h-2/10
P 12 74 126.3-42 (M 55037)P 12 74 126.3-42 (M 55037)
6. Dezember 1962 December 6 , 1962
1. August 19681st August 1968
Es wurde gefunden, daß in 4(5)-Stellung ungesättigte la-Alkylthiosteroide der allgemeinen Formel IIt has been found that in the 4 (5) position unsaturated la-alkylthiosteroids of the general formula I.
worin Ri zwei Wasserstoffatome oder ein Wasserstoffatom in α-Stellung und eine Hydroxylgruppe in /i-Stellung oder ein Sauerstoffatom, Ra ein Wasserstoffatom oder eine Acylgruppe mit 1 bis 10 Kohlenstoffatomen, Rs ein Wasserstoffatom oder einen gesättigten oder ungesättigten Kohlenwasserstoffrest mit 1 bis 3 Kohlenstoffatomen, Ra ein Wasserstoffatom oder ein Fluoratom, Ra ein Wasserstoffatom oder eine Methylgruppe und R6 einen Alkylrest mit 1 bis 3 Kohlenstoffatomen bedeutet, eine bessere anabole Wirkung bzw. einen besseren Index von anaboler zu androgener Wirkung besitzen als die entsprechenden in 1-Stellung unsubstituierten Verbindungen. wherein Ri has two hydrogen atoms or a hydrogen atom in the α-position and a hydroxyl group in the / i-position or an oxygen atom, Ra a hydrogen atom or an acyl group with 1 to 10 carbon atoms, Rs a hydrogen atom or a saturated or unsaturated hydrocarbon radical with 1 to 3 carbon atoms, Ra is a hydrogen atom or a fluorine atom, Ra is a hydrogen atom or a methyl group and R 6 is an alkyl radical with 1 to 3 carbon atoms, have a better anabolic effect or a better index of anabolic to androgenic effect than the corresponding compounds unsubstituted in the 1-position.
Es ist bekannt, Alkylmercaptane (vgl. zum Beispiel J. Org. Chemistry, Bd. 26 [1961], S. 3915 ff.) bzw. Thiofettsäuren (vgl. zum Beispiel J. Am. Chem. Soc, Bd. 81 [1959], S. 1224 ff.) an Doppelbindungen von Steroiden in saurem Medium bzw. unter Verwendung eines sauren Katalysators anzulagern, wobei die entsprechenden Alkylthio- bzw. Acylthiosteroide gebildet werden. Beim Versuch, Verbindungen der Formel I aus den entsprechenden lK4-3-Ketosteroiden unter Anwendung dieser Verfahrensweise herzustellen, wurden jedoch nur geringe Ausbeuten erzielt. Bei dem weiteren Versuch, an Stelle von sauren Katalysatoren basische Katalysatoren, vorzugsweise Amine, wie Piperidin, einzusetzen, wurden zunächst noch schlechtere Ergebnisse erzielt; nur Ausgangsmaterial wurde zurückgewonnen. It is known to use alkyl mercaptans (cf., for example, J. Org. Chemistry, Vol. 26 [1961], p. 3915 ff.) Or thio fatty acids (cf., for example, J. Am. Chem. Soc, Vol. 81 [1959 ], P. 1224 ff.) To attach to double bonds of steroids in an acidic medium or using an acidic catalyst, the corresponding alkylthio or acylthiosteroids being formed. When attempting to prepare compounds of the formula I from the corresponding 1 K4 -3-ketosteroids using this procedure, however, only low yields were achieved. In the further attempt to use basic catalysts, preferably amines, such as piperidine, instead of acidic catalysts, even worse results were initially achieved; only starting material was recovered.
Es wurde nun gefunden, daß überraschenderweise die Reaktion auch in Gegenwart von basischen Katalysatoren gelingt, daß darüber hinaus die Ausbeuten bei dieser Arbeitsweise sehr viel höher liegen und man leichter reine Produkte erhält als bei der bekannten Arbeitsweise in saurem Medium, wenn man dafür sorgt, daß vor der Aufarbeitung der basische Katalysator aus dem Reaktionsgemisch ent-Verfahren zur HerstellungIt has now been found that, surprisingly, the reaction even in the presence of basic Catalysts succeed in that, moreover, the yields in this procedure are very much higher and pure products are obtained more easily than with the known procedure in acidic medium, if it is ensured that the basic catalyst is removed from the reaction mixture prior to work-up for the production
von 1»- Alkylthio-3-keto-4-androstenenof 1 »- alkylthio-3-keto-4-androstenes
Anmelder:Applicant:
E. Merck Aktiengesellschaft,E. Merck Aktiengesellschaft,
6100 Darmstadt, Frankfurter Str. 2506100 Darmstadt, Frankfurter Str. 250
Als Erfinder benannt:Named as inventor:
Dipl.-Chem. Dr Klaus Irmscher, 6100 Darmstadt; Dipl.-Chem. Dr. Karl-Heinz Bork,Dipl.-Chem. Dr Klaus Irmscher, 6100 Darmstadt; Dipl.-Chem. Dr. Karl-Heinz Bork,
6103 Griesheim;6103 Griesheim;
Dr. Hans-Günther Kraft, 6100 DarmstadtDr. Hans-Günther Kraft, 6100 Darmstadt
fernt wird. Bei der üblichen Aufarbeitung (Eindampfen der Reaktionslösung) wurde nämlich unter dem Einfluß der Base Mercaptan abgespalten, wobei das Ausgangsmaterial zurückgebildet wurde.is removed. In the usual work-up (evaporation of the reaction solution) was namely under the Influence of the base mercaptan split off, the starting material being reformed.
■ Der basische Katalysator kann beispielsweise entfernt werden durch Aufnehmen des Reaktionsgemisches in einem inerten Lösungsmittel, wie Äther, und Waschen mit Säure, z. B. mit verdünnter Salzsäure. The basic catalyst can be removed, for example, by taking up the reaction mixture in an inert solvent such as ether and washing with acid, e.g. B. with dilute hydrochloric acid.
Gegenstand der Erfindung ist dementsprechend ein Verfahren zur Herstellung von la-Alkylthio-3-keto-4-androstenen der allgemeinen Formel I, das dadurch gekennzeichnet ist, daß man ein Alkylmercaptan mit 1 bis 3 Kohlenstoffatomen an ein . l14-3-Ketosteroid der allgemeinen FormelThe invention accordingly provides a process for the preparation of la-alkylthio-3-keto-4-androstenes of the general formula I, which is characterized in that an alkyl mercaptan having 1 to 3 carbon atoms is added. l 14 -3-ketosteroid of the general formula
OR2 OR 2
worin Ri bis R5 die angegebene Bedeutung haben, in Gegenwart eines basischen Katalysators, vorzugsweise in Gegenwart eines Amins, wie Piperidin, anlagert und vor der Isolierung der erhaltenen Verbindung den basischen Katalysator aus dem Reaktionsgemisch entfernt und daß man gegebenenfalls eine in 17/J-StelIung der erhaltenen Verbindung vorhandene Hydroxylgruppe in an sich bekannter Weise verestert. wherein Ri to R5 have the meaning given, in The presence of a basic catalyst, preferably in the presence of an amine such as piperidine, is added and before the compound obtained is isolated, the basic catalyst is removed from the reaction mixture and, if appropriate, an in 17 / J position of the connection received Hydroxyl group esterified in a manner known per se.
809 SBS/4&1809 SBS / 4 & 1
3 43 4
Die Alkylmercaptane lagern sich in glatter Reak- Salben oder Cremes, die gegebenenfalls sterilisiert tion an die l(2)-ständige Doppelbindung des obenge- oder mit Hilfsstoffen, wie Konservierungs-, Stabilinannten /I^-S-Ketosteroids an. Das Alkylmercaptan sierungs- oder Netzmitteln oder Salzen zur Beeinkann selbst als Lösungsmittel dienen, man kann aber flussung des osmotischen Druckes, oder mit Pufferauch in einem inerten organischen Lösungsmittel, 5 substanzen versetzt sind. Die Dosierung beträgt 1 bis wie Dioxan, Benzol, Dimethylformamid oder ter- 10 mg oral, 10 bis 100 mg parenteral pro Dosis, tiären Alkoholen, arbeiten. Bei der Reaktion wirdThe alkyl mercaptans are stored in smooth reac ointments or creams, which may be sterilized tion to the l (2) double bond of the above or with auxiliaries such as preservatives, stabilizers / I ^ -S-keto steroids. The alkyl mercaptanizing or wetting agents or salts for influencing serve as a solvent, but you can flow the osmotic pressure, or with a buffer in an inert organic solvent, 5 substances are added. The dosage is 1 to such as dioxane, benzene, dimethylformamide or ter- 10 mg orally, 10 to 100 mg parenterally per dose, tertiary alcohols, work. When responding will
ein basischer Katalysator zugesetzt, wie Pyridin, B e i s ο i e 1 1 Piperidin, Morpholin, ein Alkalialkoholat odera basic catalyst added, such as pyridine, B e i s o i e 1 1 Piperidine, morpholine, an alkali alcoholate or
Alkalihydroxyd. Die Reaktion kann bei Zimmertem- io 1,7 g 1-Dehydro-testosteronacetat werden in 30 mlAlkali hydroxide. The reaction can be carried out at room temperature 1.7 g of 1-dehydro-testosterone acetate in 30 ml
peratur durchgeführt werden. Sie läuft jedoch schnei- Äthylmercaptan gelöst. Die Lösung wird nach Zu-temperature can be carried out. However, it runs smoothly. Ethyl mercaptan dissolved. The solution will be
ler und glatter ab, wenn man erwärmt bzw. kocht gäbe von 0,7 ml Piperidin in einem BombenrohrLighter and smoother if you heated or boiled 0.7 ml of piperidine in a bomb tube
und/oder unter Druck, z. B. im Bombenrohr, arbeitet. 20 Stunden auf 90 bis 1000C erhitzt. Nach dem Ab-and / or under pressure, e.g. B. in the bomb tube, works. Heated to 90 to 100 ° C. for 20 hours. After leaving
Geeignete Mercaptane sind Methyl-, Äthyl-, kühlen wird mit Äther verdünnt und die Lösung nachn-Propyl- und Isopropylmercaptan. 15 einander mit verdünnter Salzsäure, Wasser, Natrium-Unter den angegebenen Reaktionsbedingungen hydrogencarbonatlösung und Wasser gewaschen, gekann es vorkommen, vor allem beim Erwärmen des trocknet und bei 40° C unter vermindertem Druck Reaktionsgemisches, daß im Molekül etwa vor- eingedampft, wobei das la-Äthylthio-testosteronhandene Estergruppen durch den Einfluß des Kataly- acetat ausfällt. Es kann aus Äther umkristallisiert sators verseift werden. Eine so in den erhaltenen Ver- 20 werden. Ausbeute 1,03 g; F. 138 bis 1400C; Xma.r bindungen entstandene oder bereits vorher vor- 241 πΐμ; EJ*m386; [α]κ + 135° (Dioxan). handene 17/?-Hydroxylgruppe kann gegebenenfallsSuitable mercaptans are methyl, ethyl, cool is diluted with ether and the solution after n-propyl and isopropyl mercaptan. 15 washed each other with dilute hydrochloric acid, water, sodium under the specified reaction conditions hydrogen carbonate solution and water, it can happen, especially when the reaction mixture is heated and dried at 40 ° C under reduced pressure, that the molecule is approximately pre-evaporated, the la -Ethylthio-testosterone-present ester groups due to the influence of the catalytic acetate precipitates. It can be saponified from ether recrystallized sators. One so in the obtained ver 20. Yield 1.03g; M.p. 138 to 140 0 C; X ma .r bonds created or already before 241 πΐμ; EJ * m 386; [α] κ + 135 ° (dioxane). existing 17 /? - hydroxyl group can optionally
nach an sich bekannten Methoden verestert werden. . -19 Als Veresterungsmittel sind alle diejenigen Säuren B e 1 s ρ 1 e 1 2 bzw. deren zur Veresterung geeigneten Derivate ver- 25 Die Lösung von 5,8 g 1-Dehydro-testosteronacetat wendbar, die physiologisch verträgliche Ester er- in 35 ml Propylmercaptan wird mit 0,7 ml Piperidin geben, z. B. Carbonsäuren, wie Essigsäure, Propion- versetzt und 24 Stunden ' im Bombenofen unter säure, Buttersäure, Trimethylessigsäure, Cyclopentyl- Schütteln auf 90° C erhitzt. Nach der wie im Beipropionsäure, Phenylpropionsäure, Capronsäure, spiel 1 durchgeführten Aufarbeitung wird in Benzol Caprylsäure, Stearinsäure, Undecylensäure, Benzoe- 30 gelöst und über eine Säule aus Kieselgel chromatosäure oder Hexahydrobenzoesäure, ferner Halogen- graphiert. Aus den Benzol-Äther-Eluaten (9:1) wird carbonsäuren, wie Chloressigsäure. Auch Dicarbon- reines la-n-Propylthio-testosteronacetat isoliert. Aussäuren, Amino- oder Alkylaminocarbonsäuren, sowie beute 3,5 g; F. 106 bis 1070C, [a]o + 140° (Dioxan). anorganische Säuren, wie Phosphor- oder Schwefelsäure, sind verwendbar. Auf diese Art lassen sich z. B. 35 R . . . herstellen: Succinate, Oxalate oder die Säureaddi- Beispiel S tionssalze von Aminocarbonsäureestern, z. B. von Analog Beispiel 2 werden 1,9 g 1-Dehydro-testo-Asparaginsäure- oder Diäthylaminoessigsäureestern. steronacetat in 20 ml Dioxan mit 10 g Methylmer-be esterified by methods known per se. . -19 All acids B e 1 s ρ 1 e 1 2 or their derivatives suitable for esterification can be used as esterification agents Propyl mercaptan is added with 0.7 ml of piperidine, e.g. B. carboxylic acids, such as acetic acid, propionic added and 24 hours' heated to 90 ° C in a bomb oven under acid, butyric acid, trimethyl acetic acid, cyclopentyl shaking. After the work-up carried out as in beipropionic acid, phenylpropionic acid, caproic acid, game 1, caprylic acid, stearic acid, undecylenic acid, benzoic acid is dissolved in benzene and chromatic acid or hexahydrobenzoic acid and also halogen graphed over a column of silica gel. The benzene-ether eluates (9: 1) become carboxylic acids, such as chloroacetic acid. Dicarbon-pure la-n-propylthio-testosterone acetate is also isolated. Extract acids, amino or alkylaminocarboxylic acids, as well as loot 3.5 g; F. 106-107 0 C, [a] o + 140 ° (dioxane). inorganic acids such as phosphoric or sulfuric acid can be used. In this way, z. B. 35 R. . . prepared: succinates, oxalates or Säureaddi- Example S addition salts of aminocarboxylic acid esters, such. B. from Example 2 are 1.9 g of 1-dehydro-testo-aspartic acid or diethylaminoacetic acid esters. sterone acetate in 20 ml of dioxane with 10 g of methyl mer-
Die Ausgangsverbindungen können erhalten wer- captan und 0,5 ml Piperidin im Bombenofen erhitzt,The starting compounds can be obtained and 0.5 ml of piperidine heated in a bomb furnace,
den durch übliche chemische oder mikrobiologische 40 Nach Chromatographie über Kieselgel wird reinesthe usual chemical or microbiological 40 After chromatography over silica gel becomes pure
1(2)-Dehydrierung der zugrunde liegenden, l4-3-Keto- lu-Methylthio-testosteronacetat erhalten. Ausbeute1 (2) -Dehydration of the underlying, l 4 -3-keto-lu-methylthio-testosterone acetate obtained. yield
steroide. ' 1,05 g; F. 198 bis 201 °C; [a]D + 119° (Dioxan);steroids. '1.05 g; M.p. 198 to 201 ° C; [a] D + 119 ° (dioxane);
Nach der Erfindung können beispielsweise die λ,««.,· 241 ηΐμ, E}'°m 387. folgenden Thioäther und deren 17-Ester hergestelltAccording to the invention, the λ, ".", 241 · ηΐμ, E} '° m 387th following thioethers and their 17-esters can be prepared, for example
werden: 45 Beispiel 4 become: 45 Example 4
la-Methylthio-testosteronacetat, ^ . , 1 -7 ' 1 γλ u j η .uila-methylthio-testosterone acetate, ^. , 1 -7 '1 γλ u j η .ui
la-Äthyithio-testosteronacetat, Das Gem^ch, %us u /'7S l-Pehydro-nrx-methyl-la-Ethyithio-testosterone acetate, Das Gem ^ ch , % us u / ' 7 S l-Pehydro-nrx-methyl-
la-n-Propylthio-testosteronacetat, testosteron 30 ml Äthylmercaptan und 0,7 ml P.pen-la-n-propylthio-testosterone acetate, testosterone 30 ml ethyl mercaptan and 0.7 ml P.pen-
la-Methylthio-testosteronpropionat, Jn w'rd 2° ,?unde" ™, Bombf rohr/uf *15 £ er-la-methylthio-testosterone propionate, J nw ' rd 2 °,? unde "™, Bomb f pipe / uf * 15 £ er
la-Methylthio-methyltestosteron, 5° hitzt. Nach dem Abkühlen wird mit Äther verdünntla-methylthio-methyltestosterone, 5 ° heats. After cooling, it is diluted with ether
la-Äthylthio-methyltestosteron, und die ^sung nacheinander mit verdünnter SaIz-la-ethylthio-methyltestosterone, and the solution one after the other with diluted salt
la-n-Propylthio-methyltestosteron. 5^ und Wasser gewaschen, getrocknet und beila-n-propylthio-methyltestosterone. 5 ^ and water washed, dried and at
40 C unter vermindertem Druck eingedampft. Der40 C evaporated under reduced pressure. Of the
Die Verfahrensprodukte können als Anabolica im Rückstand wird in der nötigen Menge Benzol gelöstThe process products can be used as anabolic steroids in the residue is dissolved in the necessary amount of benzene
Gemisch mit üblichen Arzneimittelträgern in der 55 und über Kieselgel filtriert. Aus den Eluaten wirdMixture with common excipients in the 55 and filtered through silica gel. The eluates become
Human- oder Veterinärmedizin eingesetzt werden. nach Anreiben mit Hexan reines lu-Äthylthio-Human or veterinary medicine can be used. after rubbing with hexane pure lu-ethylthio-
AIs Trägersubstanzen kommen solche organische 17a-rnethyltestosteron erhalten. Ausbeute 1,19 g;Such organic 17a-methyltestosterone are obtained as carrier substances. Yield 1.19 g;
oder anorganische Stoffe in Frage, die für die paren- F. 136 bis 139 "C; [«]« + 120° (Dioxan); /.,«„.,·or inorganic substances in question, which are suitable for the paren- F. 136 to 139 "C; [«] «+ 120 ° (dioxane); /., to ".,·
terale, enterale oder topikale Applikation geeignet 242,5 ΐημ, Ej°°m 368.Teral, enteral or topical application suitable 242.5 ΐημ, Ej °° m 368.
sind und die mit den neuen Verbindungen nicht in 60and those with the new connections are not in 60
Reaktion treten, wie beispielsweise Wasser, pflanz- B e i s η i e 1 5 liehe öle, Polyäthylenglykole, Gelatine, Milchzucker,Reaction occur, such as, for example, water, vegetable B e i s η i e 1 5 borrowed oils, polyethylene glycols, gelatine, milk sugar,
Stärke, Magnesiumstearat, Talk, Vaseline, Choleste- Die Lösung von 3 g l-Dehydro-nu-methyltesto-Starch, magnesium stearate, talc, Vaseline, Choleste- The solution of 3 g of l-dehydro-nu-methyltesto-
rin usw. Zur parenteralen Applikation dienen insbe- steron in 45 ml n-Propylmercaptan wird mit 0,9 mlrin, etc. For parenteral administration, in particular, n-propyl mercaptan in 45 ml is used with 0.9 ml
sondere Lösungen, vorzugsweise ölige oder wäßrige 65 Piperidin versetzt und 24 Stunden im Bombenofenspecial solutions, preferably oily or aqueous 65 piperidine, and put in a bomb oven for 24 hours
Lösungen, sowie Suspensionen, Emulsionen oder unter Schütteln auf 100 C erhitzt. Nach der wie imSolutions, as well as suspensions, emulsions or heated to 100 C with shaking. After the as in
Implantate. Für die enterale Applikation eignen sich Beispiel 4 durchgeführten Aufarbeitung wird überImplants. For enteral application, example 4 work-up carried out is suitable
Tabletten oder Dragees, für die topikale Anwendung Kieselgel chromatographiert. Aus den Benzol-Äther-Tablets or dragees, for topical application silica gel chromatographed. From the benzene ether
Eluaten (4 : 1) wird la-n-Propylthio-17a-methyltestosteron erhalten. Ausbeute 1,79 g; F. 82 bis 85°C (Hexan); [α]β + 121° (Dioxan); Xmax 242ηΐμ, E = 13 500.Eluates (4: 1) are obtained la-n-propylthio-17a-methyltestosterone. Yield 1.79 g; M.p. 82 to 85 ° C (hexane); [α] β + 121 ° (dioxane); X max 242ηΐμ, E = 13 500.
Das Gemisch aus 1,7 g l-Dehydro-na-methyltestosteron, 50 ml Methylmercaptan und 0,5 ml Piperidin wird im Bombenrohr 20 Stunden auf 1000C erhitzt. Nach dem Abkühlen des Reaktionsgemisches wird mit Äther verdünnt und die Lösung nacheinander mit verdünnter Salzsäure und Wasser gewaschen, getrocknet und unter vermindertem Druck eingedampft. Das so erhaltene rohe Ia-Methylthio-17tt-methy!testosteron Wird aus Äther umkristallisiert. Ausbeute 1,0 g; F. 158 bis 1600C; [α]Λ + 120° (Dioxan); Xnax 242 ηΐμ, EJ* 398.The mixture of 1.7 g l-dehydro-na-methyl testosterone, 50 ml of methyl mercaptan and 0.5 ml piperidine is heated for 20 hours at 100 0 C in a sealed tube. After the reaction mixture has cooled, it is diluted with ether and the solution is washed successively with dilute hydrochloric acid and water, dried and evaporated under reduced pressure. The crude Ia-methylthio-17tt-methy! Testosterone thus obtained is recrystallized from ether. Yield 1.0g; M.p. 158 to 160 0 C; [α] Λ + 120 ° (dioxane); X nax 242 ηΐμ, EJ * 398.
Analog Beispiel 3 werden aus 1,9 g 1-Dehydrotestosteronpropionat 0,96 g la-Methylthio-testosteronpropionat hergestellt. F. 145 bis 146°C; [o\d + 102° (Dioxan); Wr 241 ηΐμ, Ε|* 370.Analogously to Example 3, 0.96 g of 1-methylthio-testosterone propionate are prepared from 1.9 g of 1-dehydrotestosterone propionate. M.p. 145 to 146 ° C; [o \ d + 102 ° (dioxane); Wr 241 ηΐμ, Ε | * 370.
3030th
3535
a) 2 g 1-Dehydrotestosteron werden mit 11,6 ml n-Propylmercaptan und 0,32 ml Piperidin 24 Stunden im Bombenofen unter Schütteln auf 9O0C erhitzt. Nach der Aufarbeitung wie im Beispiel 1 erhält man 1,1 g la-n-Propylthio-testosteron vom F. 156 bis 157°C.a) 2 g of 1-dehydrotestosterone are heated for 24 hours in the bomb oven under shaking at 9O 0 C with 11.6 ml of n-propyl mercaptan and 0.32 ml of piperidine. After working up as in Example 1, 1.1 g of la-n-propylthio-testosterone with a melting point of 156 ° to 157 ° C. are obtained.
b) 0,4 g la-n-Propylthio-testosteron werden in einem Gemisch aus 2,5 ml Pyridin und 2,5 ml Acetanhydrid über Nacht bei Raumtemperatur stehengelassen. Dann wird in 50 ml Eiswasser eingegossen, der Niederschlag abgesaugt und aus Hexan umkristallisiert. Man erhält 0,32 g la-n-Propylthio-testosteronacetat vom F. 106 bis 1070C, das mit der nach Beispiel 2 hergestellten Substanz keine Schmelzpunktsdepression zeigt.b) 0.4 g of la-n-propylthio-testosterone are left to stand overnight at room temperature in a mixture of 2.5 ml of pyridine and 2.5 ml of acetic anhydride. It is then poured into 50 ml of ice water, the precipitate is filtered off with suction and recrystallized from hexane. 0.32 g of la-n-propylthio-testosterone acetate with a melting point of 106 to 107 ° C., which does not show any depression of the melting point with the substance prepared according to Example 2, is obtained.
Claims (1)
Journ. Org. Chem., Bd. 26 (1961), S. 3915;
Journ. Am. Chem. Soc, Bd. 81 (1959), S. 1224. 45 Publications considered:
Journ. Org. Chem. 26: 3915 (1961);
Journ. At the. Chem. Soc, 81: 1224 (1959).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM55037A DE1274126B (en) | 1962-12-06 | 1962-12-06 | Process for the preparation of 1ª ‡ -alkylthio-3-keto-4-androstenes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM55037A DE1274126B (en) | 1962-12-06 | 1962-12-06 | Process for the preparation of 1ª ‡ -alkylthio-3-keto-4-androstenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1274126B true DE1274126B (en) | 1968-08-01 |
Family
ID=7308184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEM55037A Pending DE1274126B (en) | 1962-12-06 | 1962-12-06 | Process for the preparation of 1ª ‡ -alkylthio-3-keto-4-androstenes |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1274126B (en) |
-
1962
- 1962-12-06 DE DEM55037A patent/DE1274126B/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| None * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1274126B (en) | Process for the preparation of 1ª ‡ -alkylthio-3-keto-4-androstenes | |
| DE1198818B (en) | Process for the production of 2, 3-epithiosteroids | |
| CH509997A (en) | Hormone active steroids | |
| DE2109555C3 (en) | New 15 a, 16 a -methylene steroids, drugs containing them and processes for their production | |
| DE2256537A1 (en) | NEW SULPHIDES | |
| DE1215702B (en) | Process for the preparation of 1alpha-alkylthio-3-keto-androstanes | |
| DE1254149B (en) | Process for the preparation of 1alpha, 7alpha-dialkylthio-3-keto-4-androstenes | |
| AT253142B (en) | Process for the production of new sulfur-containing androstane derivatives | |
| DE1264441B (en) | Process for the production of 17alpha-AEthynyl-delta 5 (10-19-nor-androsten-17beta-ol-3-one and 17alpha-AEthynil-19-nor-testosterone and its esters | |
| DE2444728A1 (en) | PROCESS FOR PRODUCING NEW ANTIBIOTICALLY ACTIVE COMPOUNDS | |
| DE2101813C3 (en) | New 17alpha- (2 ', 3'-difluoromethylene prop-1' -en-1 '-yl) -östra-4-en-3-ones, processes for their preparation and agents containing them | |
| DE1198356B (en) | Process for the production of sulfur-containing androstane derivatives | |
| AT270893B (en) | Process for the preparation of new 19-alkenyl steroids | |
| DE1158507B (en) | Process for the preparation of 6a-methyl-16-methylene-steroids | |
| DE1072243B (en) | Process for the preparation of water-soluble cortisone derivatives | |
| AT270884B (en) | Process for the preparation of new 4,6-pregnadiene derivatives | |
| AT275754B (en) | Process for the preparation of new 16-methylene-19-nor-progesterone derivatives | |
| DE1468901A1 (en) | Process for the preparation of 16alpha-AEthynyl-19-nor-1,3,5 (10) -androstatrienes | |
| DE1203768B (en) | Process for the preparation of N-substituted 4-amino steroids of the testosterone series and acid addition salts thereof | |
| DE1243681B (en) | Process for the preparation of 4-mercapto derivatives of the testosterone or 19-nor-testosterone series and of S-alkyl and S-acyl derivatives of the same | |
| DE1225638B (en) | Process for the preparation of 7alpha-alkylthio-17alpha-methyl-testosterones | |
| DE2243574A1 (en) | Carbazolyl- and phenothiazinyl oxy acetic acid derivs - against coronary diseases and atherosclerosis from corresp. heterocyclic hydroxy-cpds. and halo acetic esters | |
| DE2101813B2 (en) | New 17alpha- (2,3-difluoromethylene-prop-1'-en-1'-yl) -östra-4-en-3-ones, processes for their preparation and agents containing them | |
| DE1222496B (en) | Process for the preparation of 1alpha-alkoxy-3-keto-androstanes | |
| CH405286A (en) | Process for the production of new sulfonamides |